Catheter Ablation of Atrial Fibrillation in Patients With Functional Mitral Regurgitation and Left Ventricular Systolic Dysfunction

The efficacy of catheter ablation for atrial fibrillation (AF) in patients with functional mitral regurgitation (MR) and left ventricular (LV) systolic dysfunction (LVSD) is not known. The aim of the study is to determine the efficacy of catheter ablation for AF in patients with functional MR and LV...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cardiovascular medicine Vol. 7; p. 596491
Main Authors Wu, Jin-Tao, Zaman, Junaid A B, Yakupoglu, H Yakup, Vennela, Boyalla, Emily, Cantor, Nabeela, Karim, Jarman, Julian, Haldar, Shouvik, Jones, David Gareth, Wajid, Hussain, Shi, Rui, Chen, Zhong, Markides, Vias, Wong, Tom
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 14.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The efficacy of catheter ablation for atrial fibrillation (AF) in patients with functional mitral regurgitation (MR) and left ventricular (LV) systolic dysfunction (LVSD) is not known. The aim of the study is to determine the efficacy of catheter ablation for AF in patients with functional MR and LVSD, and to validate its effects on the severity of MR and cardiac reverse remodeling. We performed a retrospective study of 54 patients with functional MR who underwent AF ablation, including 21 (38.9%) with LVSD and 33 (61.1%) with normal LV systolic function (LVF). The primary outcomes evaluated were freedom from recurrent atrial tachyarrhythmia (ATa), severity of MR, and left atrial (LA) and LV remodeling. During a mean follow-up of 20.7 ± 16.8 months, freedom from recurrent ATa was not significantly different between patients with LVSD and those with normal LVF after the first ablation ( = 0.301) and after multiple ablations ( = 0.728). Multivariable predictors of recurrent ATa were AF duration [hazard ratio (HR) 1.12, 95% confidence interval (CI) 1.01-1.25; = 0.039), previous stroke (HR 5.28, 95% CI 1.46-19.14; = 0.011), and estimated glomerular filtration rate (HR 0.97, 95% CI 0.95-0.99; = 0.012). Compared with baseline, there was a significant reduction in severity of MR ( = 0.007), LA size ( < 0.001) and LV end-systolic dimension ( = 0.008), and improvement in the LV ejection fraction ( = 0.001) after restoring sinus rhythm in patients with LVSD. Catheter ablation is a valid option for the treatment of AF in patients with functional MR and LVSD, even though multiple procedures may be required.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Didier Locca, Queen Mary University of London, United Kingdom
Reviewed by: Paolo Denti, San Raffaele Hospital (IRCCS), Italy; David Chistian Reineke, Inselspital, Switzerland
This article was submitted to Structural Interventional Cardiology, a section of the journal Frontiers in Cardiovascular Medicine
ISSN:2297-055X
2297-055X
DOI:10.3389/fcvm.2020.596491